UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

31 Intracranial growing teratoma syndrome (IGTS): An international retrospective study

Canadian journal of neurological sciences, 2018-06, Vol.45 (S3), p.S13-S13

2018

Volltextzugriff (PDF)

HGG-48. THE BLOOD-BASED TELOMERIC DNA C-CIRCLE ASSAY CAN DETECT ALTERNATIVE LENGTHENING OF TELOMERES (ALT) IN PEDIATRIC HIGH-GRADE GLIOMAS

Neuro-oncology (Charlottesville, Va.), 2024-06, Vol.26 (Suppl 4), p.0-0

2024

Volltextzugriff (PDF)

Abstract CT029: Pediatric phase 2 trial of the WEE1 inhibitor adavosertib (AZD1775) and irinotecan: A Children's Oncology Group Study (ADVL1312)

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.CT029-CT029

2021

Volltextzugriff (PDF)

METB-14. INTEGRATED GERMLINE AND SOMATIC PROFILING OF PEDIATRIC BRAIN TUMORS REVEALS INCIDENTAL FINDINGS AND NOVEL TUMOR BIOLOGY

Neuro-oncology (Charlottesville, Va.), 2024-06, Vol.26 (Suppl 4), p.0-0

2024

Volltextzugriff (PDF)

GABAergic neuronal lineage development determines clinically actionable targets in diffuse hemispheric glioma, H3G34-mutant

Cancer cell, 2024-09, Vol.42 (9), p.1528-1548.e17

2024

Volltextzugriff (PDF)

METB-09. GERMLINE PATHOGENIC VARIANTS IN 838 PEDIATRIC BRAIN TUMOR PATIENTS

Neuro-oncology (Charlottesville, Va.), 2023-06, Vol.25 (Supplement_1), p.i32-i32

2023

Volltextzugriff (PDF)

Abstract CT144: Pediatric phase I trial of the WEE1 inhibitor AZD1775 and irinotecan in patients with refractory solid and CNS malignancies; A Children’s Oncology Group Study (ADVL1312)

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.CT144-CT144

2017

Volltextzugriff (PDF)

Phase I Clinical Trial of the Wee1 inhibitor Adavosertib (AZD1775) with Irinotecan in Children with Relapsed Solid Tumors. A COG Phase 1 Consortium Report (ADVL1312)

Clinical cancer research, 2019-12, Vol.26 (6), p.1213-1219

2019

Volltextzugriff (PDF)

Abstract 4305: NMI as a biomarker of response to CDK4/6 inhibition in a preclinical model of neuroblastoma

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.4305-4305

2015

Volltextzugriff (PDF)

HGG-20. DIAGNOSTIC AND BIOLOGICAL ROLE OF METHYLATION PATTERNS IN REPLICATION REPAIR DEFICIENT HIGH GRADE GLIOMAS

Neuro-oncology (Charlottesville, Va.), 2020-12, Vol.22 (Supplement_3), p.iii347-iii348

2020

Volltextzugriff (PDF)

Abstract LB-B13: Pediatric Preclinical Testing Consortium evaluation of the CHK1 inhibitor prexasertib

Molecular cancer therapeutics, 2018-01, Vol.17 (1_Supplement), p.LB-B13-LB-B13

2018

Volltextzugriff (PDF)

HGG-06. EARLY GABAERGIC NEURONAL LINEAGE DEFINES DEPENDENCIES IN HISTONE H3 G34R/V GLIOMA

Neuro-oncology (Charlottesville, Va.), 2021-06, Vol.23 (Supplement_1), p.i18-i18

2021

Volltextzugriff (PDF)

Abstract A2-09: Oncogenic dysregulations in neuroblastoma are associated with distal large chromosomal aberrations

Cancer research (Chicago, Ill.), 2015-11, Vol.75 (22_Supplement_1), p.A2-A2-09

2015

Volltextzugriff (PDF)

Abstract PR10: Oncogenic dysregulations in neuroblastoma are associated with distal large chromosomal aberrations

Cancer research (Chicago, Ill.), 2015-11, Vol.75 (22_Supplement_2), p.PR10-PR10

2015

Volltextzugriff (PDF)

Abstract 6372: Germline pathogenic variants are enriched in pediatric central nervous system tumor patients and associate with somatic functional consequences

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.6372-6372

2024

Volltextzugriff (PDF)

PDTM-21. LARGE SCALE TUMOR MUTATIONAL BURDEN ANALYSIS OF PEDIATRIC TUMORS PROVIDES A DIAGNOSTIC TOOL FOR GERMLINE PREDISPOSITION AND REVEALS NOVEL CANDIDATES FOR IMMUNE CHECKPOINT INHIBITION

Neuro-oncology (Charlottesville, Va.), 2017-11, Vol.19 (suppl_6), p.vi194-vi194

2017

Volltextzugriff (PDF)

Abstract 4758: Inhibition of checkpoint kinase 1 (Chk1) as a potential therapeutic for pediatric neuroblastoma

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.4758-4758

2011

Volltextzugriff (PDF)

HGG-17. TUMOR MUTATIONAL BURDEN ANALYSIS OF PEDIATRIC TUMORS PROVIDES A DIAGNOSTIC TOOL FOR GERMLINE REPLICATION REPAIR DEFICIENCY AND PREDICT RESPONSE TO IMMUNE CHECKPOINT INHIBITION

Neuro-oncology (Charlottesville, Va.), 2018-06, Vol.20 (suppl_2), p.i92-i92

2018

Volltextzugriff (PDF)

Abstract 1436: Therapeutic targeting of the DNA damage mediators CHK1 and Wee1 in neuroblastoma

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.1436-1436

2012

Volltextzugriff (PDF)

HGG-20. DNA METHYLATION ANALYSIS OF HIGH-GRADE GLIOMA IN PATIENTS WITH MISMATCH REPAIR DEFICIENCIES

Neuro-oncology (Charlottesville, Va.), 2018-06, Vol.20 (suppl_2), p.i92-i93

2018

Volltextzugriff (PDF)

GERM-23. INTRACRANIAL GROWING TERATOMA SYNDROME (IGTS): AN INTERNATIONAL RETROSPECTIVE STUDY

Neuro-oncology (Charlottesville, Va.), 2018-06, Vol.20 (suppl_2), p.i88-i88

2018

Volltextzugriff (PDF)

COMBINATION THERAPY TARGETING THE CHK1 AND WEE1 KINASES DEMONSTRATES THERAPEUTIC EFFICACY IN NEUROBLASTOMA

Cancer research (Chicago, Ill.), 2012-11, Vol.73 (2), p.776-784

2012

Volltextzugriff (PDF)

Histopathology and molecular biology of ovarian epithelial tumors

Annals of diagnostic pathology, 1998-06, Vol.2 (3), p.195-207

1998

Volltextzugriff (PDF)

Abstract 4871: New neuroblastoma susceptibility loci at 6q21 within HACE1 and LIN28B

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.4871-4871

2012

Volltextzugriff (PDF)

Abstract 5263: An RNAi screen of the protein kinome identifies CHEK1 as a therapeutic target in neuroblastoma

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.5263-5263

2010

Volltextzugriff (PDF)

1 – 25 von 209

Suche als RSS-Feed

Aktive Filter

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(192)
Mit Volltextzugriff
(189)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

31 Intracranial growing teratoma syndrome (IGTS): An international retrospective study

HGG-48. THE BLOOD-BASED TELOMERIC DNA C-CIRCLE ASSAY CAN DETECT ALTERNATIVE LENGTHENING OF TELOMERES (ALT) IN PEDIATRIC HIGH-GRADE GLIOMAS

Abstract CT029: Pediatric phase 2 trial of the WEE1 inhibitor adavosertib (AZD1775) and irinotecan: A Children's Oncology Group Study (ADVL1312)

METB-14. INTEGRATED GERMLINE AND SOMATIC PROFILING OF PEDIATRIC BRAIN TUMORS REVEALS INCIDENTAL FINDINGS AND NOVEL TUMOR BIOLOGY

GABAergic neuronal lineage development determines clinically actionable targets in diffuse hemispheric glioma, H3G34-mutant

METB-09. GERMLINE PATHOGENIC VARIANTS IN 838 PEDIATRIC BRAIN TUMOR PATIENTS

Abstract CT144: Pediatric phase I trial of the WEE1 inhibitor AZD1775 and irinotecan in patients with refractory solid and CNS malignancies; A Children’s Oncology Group Study (ADVL1312)

Phase I Clinical Trial of the Wee1 inhibitor Adavosertib (AZD1775) with Irinotecan in Children with Relapsed Solid Tumors. A COG Phase 1 Consortium Report (ADVL1312)

Abstract 4305: NMI as a biomarker of response to CDK4/6 inhibition in a preclinical model of neuroblastoma

HGG-20. DIAGNOSTIC AND BIOLOGICAL ROLE OF METHYLATION PATTERNS IN REPLICATION REPAIR DEFICIENT HIGH GRADE GLIOMAS

Abstract LB-B13: Pediatric Preclinical Testing Consortium evaluation of the CHK1 inhibitor prexasertib

HGG-06. EARLY GABAERGIC NEURONAL LINEAGE DEFINES DEPENDENCIES IN HISTONE H3 G34R/V GLIOMA

Abstract A2-09: Oncogenic dysregulations in neuroblastoma are associated with distal large chromosomal aberrations

Abstract PR10: Oncogenic dysregulations in neuroblastoma are associated with distal large chromosomal aberrations

Abstract 6372: Germline pathogenic variants are enriched in pediatric central nervous system tumor patients and associate with somatic functional consequences

PDTM-21. LARGE SCALE TUMOR MUTATIONAL BURDEN ANALYSIS OF PEDIATRIC TUMORS PROVIDES A DIAGNOSTIC TOOL FOR GERMLINE PREDISPOSITION AND REVEALS NOVEL CANDIDATES FOR IMMUNE CHECKPOINT INHIBITION

Abstract 4758: Inhibition of checkpoint kinase 1 (Chk1) as a potential therapeutic for pediatric neuroblastoma

HGG-17. TUMOR MUTATIONAL BURDEN ANALYSIS OF PEDIATRIC TUMORS PROVIDES A DIAGNOSTIC TOOL FOR GERMLINE REPLICATION REPAIR DEFICIENCY AND PREDICT RESPONSE TO IMMUNE CHECKPOINT INHIBITION

Abstract 1436: Therapeutic targeting of the DNA damage mediators CHK1 and Wee1 in neuroblastoma

HGG-20. DNA METHYLATION ANALYSIS OF HIGH-GRADE GLIOMA IN PATIENTS WITH MISMATCH REPAIR DEFICIENCIES

GERM-23. INTRACRANIAL GROWING TERATOMA SYNDROME (IGTS): AN INTERNATIONAL RETROSPECTIVE STUDY

COMBINATION THERAPY TARGETING THE CHK1 AND WEE1 KINASES DEMONSTRATES THERAPEUTIC EFFICACY IN NEUROBLASTOMA

Histopathology and molecular biology of ovarian epithelial tumors

Abstract 4871: New neuroblastoma susceptibility loci at 6q21 within HACE1 and LIN28B

Abstract 5263: An RNAi screen of the protein kinome identifies CHEK1 as a therapeutic target in neuroblastoma

Aktive Filter

Suchergebnisse filtern